This mid­west­ern CD­MO just picked up 3 ac­qui­si­tions in less than a week

A rel­a­tive­ly qui­et Min­neapo­lis-based CD­MO is mak­ing waves, an­nounc­ing its third ac­qui­si­tion in just one week.

Pace has ac­quired Ve­le­sco Phar­ma­ceu­ti­cals Ser­vices, which will add to its liq­uid, se­mi-sol­id and oral sol­id dose man­u­fac­tur­ing, the com­pa­ny said. The CD­MO has al­so brought on BC Lab­o­ra­to­ries out of Cal­i­for­nia and Pro­Science An­a­lyt­i­cal Ser­vices

The Ve­le­sco ac­qui­si­tion al­lows Pace to broad­en its drug de­liv­ery op­tions, and tai­lor them for clients’ mod­ules, dose range and drug de­liv­ery route. With the ac­qui­si­tion, Pace will get Ve­le­sco’s clin­i­cal tri­al man­u­fac­tur­ing ca­pac­i­ty, which in­cludes spe­cial­ized, small-scale cus­tomized ex­per­i­ments, soft­gel cap­sule, sus­pen­sion and non-ster­ile liq­uid drug sup­port and ex­per­tise in non-clin­i­cal tox­i­col­o­gy stud­ies.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER